Alternatived Products of [ 1352523-65-9 ]
Product Details of [ 1352523-65-9 ]
CAS No. : 1352523-65-9
MDL No. : N/A
Formula :
C29 H20 O8
Boiling Point :
-
Linear Structure Formula : -
InChI Key : XLAQIJUJESBMLX-UHFFFAOYSA-N
M.W :
496.46
Pubchem ID : 56838315
Synonyms :
Calculated chemistry of [ 1352523-65-9 ]
Physicochemical Properties
Num. heavy atoms :
37
Num. arom. heavy atoms :
24
Fraction Csp3 :
0.03
Num. rotatable bonds :
8
Num. H-bond acceptors :
8.0
Num. H-bond donors :
4.0
Molar Refractivity :
134.39
TPSA :
149.2 Ų
Pharmacokinetics
GI absorption :
Low
BBB permeant :
No
P-gp substrate :
No
CYP1A2 inhibitor :
No
CYP2C19 inhibitor :
Yes
CYP2C9 inhibitor :
Yes
CYP2D6 inhibitor :
No
CYP3A4 inhibitor :
Yes
Log Kp (skin permeation) :
-5.35 cm/s
Lipophilicity
Log Po/w (iLOGP) :
1.33
Log Po/w (XLOGP3) :
5.6
Log Po/w (WLOGP) :
4.14
Log Po/w (MLOGP) :
1.12
Log Po/w (SILICOS-IT) :
5.4
Consensus Log Po/w :
3.52
Druglikeness
Lipinski :
0.0
Ghose :
None
Veber :
1.0
Egan :
1.0
Muegge :
1.0
Bioavailability Score :
0.55
Water Solubility
Log S (ESOL) :
-6.4
Solubility :
0.000199 mg/ml ; 0.0000004 mol/l
Class :
Poorly soluble
Log S (Ali) :
-8.5
Solubility :
0.00000159 mg/ml ; 0.0000000032 mol/l
Class :
Poorly soluble
Log S (SILICOS-IT) :
-7.32
Solubility :
0.0000239 mg/ml ; 0.0000000481 mol/l
Class :
Poorly soluble
Medicinal Chemistry
PAINS :
0.0 alert
Brenk :
1.0 alert
Leadlikeness :
3.0
Synthetic accessibility :
2.63
Safety of [ 1352523-65-9 ]
Application In Synthesis of [ 1352523-65-9 ]
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Downstream synthetic route of [ 1352523-65-9 ]
1
[ 105309-59-9 ]
[ 1352523-65-9 ]